Evonik stock falls as JPMorgan sticks to Underweight after site closure plan

Published on 09/11/2026 at 18:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik stock traded at EUR 17.89 on Xetra on September 11, 2026, down 1.35 percent from the prior close as JPMorgan reaffirmed its Underweight rating. The group also plans to close its Hamburg and Bitterfeld sites in Germany in 2027, sharpening its cost focus.

Fotorealistisches Luftbild eines Spezialchemiewerks mit Destillationstürmen bei Sonnenuntergang — Evonik Industries DE000EVNK013 zeigt ein fotorealistisches Luftbild eines großen Spezialchemiewerks bei Abenddämmerung, Illustration mit AI erstellt.

Evonik Industries stock (ISIN DE000EVNK013) traded at EUR 17.89 on Xetra on September 11, 2026, down 1.35 percent from the prior close of EUR 18.13 as of 12:33 p.m. Central European Time, highlighting investor caution around the specialty chemicals group.

JPMorgan maintains Underweight rating with 14-euro target

According to Investing.com on September 11, 2026, Evonik stock was quoted at EUR 17.89 on Xetra, a decline of 1.35 percent compared with the Xetra close of EUR 18.13, while JPMorgan analyst Chetan Udeshi reaffirmed his Underweight recommendation with a price target of EUR 14.00, implying downside of around 21.8 percent from that intraday level.

The same overview from Investing.com notes a fair value estimate for Evonik shares at EUR 19.77 based on the InvestingPro model, which corresponds to potential upside of 10.6 percent versus the EUR 17.89 price but comes with a wide model range of EUR 9.52 to EUR 27.61, underlining the high earnings uncertainty that keeps some analysts cautious.

Evonik plans to close Hamburg and Bitterfeld sites

As Zonebourse reported on September 11, 2026, Evonik announced that it intends to close its Hamburg and Bitterfeld sites in Germany over the course of the next year as part of a restructuring of its German specialty chemicals footprint, with the company stating that activities will be redistributed across other locations.

According to the same Reuters-based report on Zonebourse, Evonik shares were down about 1.46 percent on the day when the closure plan was communicated, suggesting that investors see both cost-saving potential and structural challenges in the domestic chemicals market, with high local costs and subdued demand remaining a pressure point.

Analyst view highlights structural headwinds

Investor-SMS summarized on September 11, 2026 that JPMorgan continues to rate Evonik at Underweight, arguing that European chemical producers like Evonik face structural competitive disadvantages due to high regional energy and labor costs, weak demand and strong import pressure, despite recent political signals that appear more protectionist and supportive for the sector.

The cautious stance is reflected in the price target comparison: with the JPMorgan target at EUR 14.00 and the InvestingPro fair value at EUR 19.77 per the overview on Investing.com, the spread of EUR 5.77 between the two reference values illustrates how divided expert opinion remains on the medium-term earnings power and valuation of Evonik.

Stock trades within a wide modeled range

The same price snapshot on Investing.com indicates that the modelled fair value range for Evonik shares runs from EUR 9.52 to EUR 27.61, so the EUR 17.89 Xetra price on September 11, 2026 sits roughly in the middle of that band, leaving room in both directions depending on how margins, volumes and restructuring measures develop.

For investors, the combination of the site closures in Hamburg and Bitterfeld, the structural headwinds flagged by JPMorgan and the relatively moderate upside in the InvestingPro fair value compared with the current price means that execution on efficiency programs and demand recovery will be key in determining whether Evonik stock can move closer to the upper end of its valuation range in the coming quarters.

Evonik stock price on Xetra

On Xetra, Evonik Industries stock traded at EUR 17.89 on September 11, 2026 at 12:33 p.m. Central European Time, down 1.35 percent from the prior closing price of EUR 18.13, with the fair value model on InvestingPro placing the shares at EUR 19.77 and indicating a wide model band between EUR 9.52 and EUR 27.61 that reflects the uncertainty around future earnings and cash flows.